Allison Jeynes-Ellis

651 citations
5 papers · 400 indexed · 1 hit paper · h-index 4
Topics
Asthma and respiratory diseases (2 papers)Chronic Lymphocytic Leukemia Research (2 papers)Chronic Myeloid Leukemia Treatments (2 papers)

In The Last Decade

Allison Jeynes-Ellis

5 papers receiving 389 citations

Hit Papers

Bosutinib Versus Imatinib for Newly Diagnosed Chronic Mye...20172026202020232017100200300

Peers

Allison Jeynes-Ellis
Comparison fields: 5 of 56
  • Hematology 282
  • Genetics 224
  • Rheumatology 124
  • Oncology 79
  • Pulmonary and Respiratory Medicine 70
Replace Erika M. Mosesón with:
Erika M. Mosesón United States
Dawn Maze Canada
Hoffbrand Av United Kingdom
Gholamreza Toogeh Iran
Odoardo Maria Olimpieri Italy
Christos Poziopoulos Greece
Valentina Giai Italy
Elena Mishchenko Israel
Lotta Ohm Sweden
Mahran Shoukier United States
Allison Jeynes-Ellis relative to Erika M. Mosesón United States Erika M. Mosesón's profile →
Citations per field
00.5×10×15.5×
Erika M. Mosesón · 1×
Citations per year

Countries citing papers authored by Allison Jeynes-Ellis

Since Specialization
Citations

This map shows the geographic impact of Allison Jeynes-Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison Jeynes-Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison Jeynes-Ellis more than expected).

Fields of papers citing papers by Allison Jeynes-Ellis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison Jeynes-Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison Jeynes-Ellis. The network helps show where Allison Jeynes-Ellis may publish in the future.

Co-authorship network of co-authors of Allison Jeynes-Ellis

This figure shows the co-authorship network connecting the top 25 collaborators of Allison Jeynes-Ellis. A scholar is included among the top collaborators of Allison Jeynes-Ellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison Jeynes-Ellis. Allison Jeynes-Ellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1 3
2 61
3
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trialbreakdown →
320
4 7
5 9

About Allison Jeynes-Ellis

Allison Jeynes-Ellis is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 5 papers that have together received 400 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Hematology (282 citations), Genetics (224 citations) and Rheumatology (124 citations). Allison Jeynes-Ellis has collaborated with scholars based in United States, Italy and Singapore. Frequent co-authors include Charles Chuah, Philipp le Coutre, Valentín García‐Gutiérrez, Andreas Hochhaus, Iryna Dyagil, Nathalie Bardy‐Bouxin, Jörge E. Cortes, Eric Leip, Michael J. Mauro and Tim H. Brümmendorf. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Therapeutic Advances in Respiratory Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026